BYOOVIZ
BYOOVIZ
Approved
DIN Number
02525852
Drug Class
Human
Market Date
Mar 1, 2023
Company
HC
Samsung Bioepis Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02525852
AIG Number0152224001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
S01LA04 RANIBIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RANIBIZUMABActive
Strength: 10 MG / ML
Monograph: RANIBIZUMAB